close

Log in

Access to premium content is restricted to healthcare professionals / registered members. Login with your email address to continue.

Forgot Your Password?

Don't have an account? Sign up

This site is intended for Healthcare Professionals only

module menu icon

COPD: part three

Introduction

Pharmacological therapies 1

Pharmacological therapies 2

Inhaled therapies

Inhaled triple therapy

module menu icon Inhaled therapies

You’re doing great.  (0% complete)

quiz close icon

module menu icon Inhaled therapies

The key principles for inhaled therapies in COPD are:

  • Minimise the number of inhalers, as well as the number of different types of inhaler device used by each person as far as possible
  • Only prescribe inhalers after people have been trained to use them and can demonstrate satisfactory technique
  • When dispensing inhalers, ensure people receive inhalers they have been trained to use – i.e. do not switch between brands or branded generics
  • People living with COPD should have their ability to use an inhaler regularly assessed, and optimised if necessary, by a healthcare professional competent to do so.

    • NICE guideline NG115 initiates inhaled therapy with a short-acting bronchodilator and then progresses to dual long-acting bronchodilator therapy (LABA+LAMA). For patients exhibiting asthmatic features, the dual therapy would be initiated with ICS+LABA rather than LABA+LAMA.

    Patients using long-acting therapy outside of the new recommendations can continue on current treatment and change after review with their healthcare professional when both of them agree it is appropriate.

    COPD: part three

    Continue Module
    Change privacy settings